bioRxivBiochemistryPreprint
Cryo-EM of ATP-driven dynamics and itraconazole binding of the fungal drug efflux ABC pump Candida glabrata Cdr1
Jorgaq PataiD, Benjamin WisemaniD, Eleftherios ZarkadasiD, Rim BaccouchiD, Nour Samrouth, Celia Desbois, Loïck MoissonnieriD, Alexis MorénoiD, Atanu BanerjeeiD, Stephanie AgueroiD, Emmanuel BettleriD, Marie DujardiniD, Sandrine MagnardiD, Raphaël TerreuxiD, Guy SchoehniD, Martin HögbomiD, Ahcène BoumendjeliD, Erwin LampingiD, Richard David CannoniD, Rajendra PrasadiD, Vincent ChaptaliD, Pierre FalsoniD
Abstract
Azole resistance in Candida species is often caused by the overexpression of Cdr1. Despite its clinical relevance, the structural basis for its ATP-driven efflux pump function remains elusive. We present four high-resolution cryo-EM structures for Candida glabrata Cdr1 under active turnover conditions in the absence and presence of ATP-Mg{superscript 2}, itraconazole, and vanadate. Additional transient cryo-EM structures were unveiled by 3D variability analysis offering a detailed view of the step-by-step transitions triggered by ATP-hydrolysis. The motion cascade starts with a 4 [A] piston-like retraction of the C-helix from the {gamma}-phosphate/vanadate of the hydrolyzed ATP. This causes the nearby transmembrane helix-1 (TMH-1) to open the drug-binding site via lateral displacement and unwinding of the inner-leaflet region of TMH-2. A reverse squeeze-and-push motion of TMH-2 possibly drives substrate extrusion. High resolution structures also reveal how itraconazole adapts its shape to fit into the drug-binding site. Our findings provide a dynamic structural framework for Cdr1-mediated azole resistance and the conserved chemo-mechanical cycle of ABC proteins, including non-membranous members.
- organism: fungi (other)
- assay: cryo-EM
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The immunosuppressant tacrolimus (FK506) inhibits C. glabrata Cdr1 efflux pump function by stabilizing the inward-facing conformation.
Rim Baccouch, Theo Benefice, … Vincent Chaptal·bioRxiv·Jul 8, 2026
- Structure, dynamics and evolution of the Candida albicans multi-drug resistance ABC transporter CDR1
Jeeeun Shin, Ruitao Jin, … Joseph Brock·bioRxiv·Oct 28, 2024
- Fpk1 regulates Cdr1 expression and ergosterol homeostasis in Nakaseomyces glabratus (Candida glabrata) during azole exposure
Samuel Cobb, Chelsea Chanheng, … Bao G. Vu·bioRxiv·Aug 18, 2026
- Multiple mechanisms impact fluconazole resistance of mutant Erg11 proteins in Candida glabrata
Bao Gia Vu, Scott Moye-Rowley·bioRxiv·Jun 23, 2021
- Cryo-EM structure of an elusive pre-transport intermediate of the multidrug transporter BmrCD reveals modes of asymmetric drug binding
T. M. Thaker, S. Mishra, … T. M. Tomasiak·bioRxiv·Mar 13, 2021
- Similarities and distinctions in the activation of the Candida glabrata Pdr1 regulatory pathway by azole and non-azole drugs
Thomas P. Conway, Bao Gia Vu, … Scott Moye-Rowley·mSpherePeer-reviewed·Nov 18, 2024